Reports for Commave Therapeutics SA
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About Commave Therapeutics SA
- Commave Therapeutics SA has its legal headquarters in Genève and is active. It operates in the sector «Operation of investment companies».
- The company was founded on 19.12.2017 and has 5 persons in its management.
- The company has last changed their commercial register entry on 04.06.2025, under «Notifications» you will find all changes.
- In the commercial register the company Commave Therapeutics SA is registered under the UID CHE-377.777.355.
- On the same address there are 17 other active companies registered. These include: Auregen BioTherapeutics SA, B-FLEXION Advisors (Switzerland) SA, B-FLEXION Group Holdings SA.
Management (5)
newest board members
Alessandro Berti,
Peter Agnes,
Nicolas Schnyder,
Frédéric Yves Boder
newest authorized signatories
Alessandro Berti,
Peter Agnes,
Nicolas Schnyder,
Grégory Deballe,
Frédéric Yves Boder
Commercial register information
Entry in the commercial register
19.12.2017
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Genève
Commercial Registry Office
GE
Commercial register number
CH-660.3.815.017-0
UID/VAT
CHE-377.777.355
Sector
Operation of investment companies
Purpose (Original language)
Prise de participations dans des sociétés suisses ou étrangères, acquisition, vente, détention et gestion de titres de participations, de licences, de brevets ou de tout autre droit, et de produits pharmaceutiques (y compris de produits à développer), à l'exclusion de toute opération prohibée par la LFAIE (cf. statuts pour but complet).
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| Ernst & Young SA | Lancy | 22.03.2021 | ||
Other company names
Past and translated company names
- BOSTON PHARMACEUTICALS HOLDINGS SA
Branches (0)
Ownership structure
Holdings
Newest SOGC notifications: Commave Therapeutics SA
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1006348239, Commercial Registry Office Geneva, (660)
Commave Therapeutics SA, à Genève, CHE-377.777.355 (FOSC du 16.08.2024, p. 0/1006108690). De Luca Giampiero n'est plus administrateur;
ses pouvoirs sont radiés. Berti Alessandro, de et à Satigny, est membre du conseil d'administration avec signature collective à deux.
Publication number: HR02-1006108690, Commercial Registry Office Geneva, (660)
Commave Therapeutics SA, à Genève, CHE-377.777.355 (FOSC du 22.05.2024, p. 0/1006037375). Meister Stefan n'est plus administrateur;
ses pouvoirs sont radiés. L'administrateur Agnes Peter, nommé président, continue à signer collectivement à deux.
Publication number: HR02-1006037375, Commercial Registry Office Geneva, (660)
Commave Therapeutics SA, à Genève, CHE-377.777.355 (FOSC du 23.04.2024, p. 0/1006016029). Agnes Peter, des USA, à Weston, USA, est membre du conseil d'administration avec signature collective à deux.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.